Vimarsana
Biggest News Aggregation in the World

Page 2 - Brian Markison News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brian Markison. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brian Markison Today - Breaking & Trending Today

Lantheus Stock Falls 4% Over Announcement Of CEO Succession Plan - Vimarsana News

Lantheus Stock Falls 4% Over Announcement Of CEO Succession Plan

Radiopharmaceutical company, Lantheus Holdings's (LNTH) stock slipped 4 percent on Tuesday following the company's announcement that its Chief Executive Officer Mary Heino will be succeeded by Brian Markison, effective March 1.

RVL Completes Financial Restructuring - Vimarsana News

RVL Completes Financial Restructuring

27.11.2023 - Athyrium Provides Capital to Support Long-Term Growth and Exchanges Outstanding Debt into Equity of Certain Reorganized Entities RVL Pharmaceuticals plc Ordinary Shares Expected to be Cancelled in 2024 BRIDGEWATER, N.J., Nov. 27, 2023 (GLOBE ...

RVL Pharmaceuticals plc Announces Prepackaged Reorganization of Certain U.S. Subsidiaries - Vimarsana News

RVL Pharmaceuticals plc Announces Prepackaged Reorganization of Certain U.S. Subsidiaries

Lender to Provide Incremental Liquidity to Support Long-Term Growth Senior Secured Lender to Exchange Outstanding Debt into Equity of the Reorganized Entities Business Operations at U.S. Subsidiaries to Continue as They Pursue Strategic Plan RVLP Ordinary Shares Expected to be Cancelled BRIDGEWATER, N.J., Oct. 12, 2023 (GLOBE NEWSWIRE) -- RVL Pharmaceuticals plc (“RVL” or “the Company”), a specialty pharmaceutical company focused on the commercialization of UPNEEQ® (oxymetazoline hydrochloride o

Source: yahoo.com
How to get your DC ready for driverless forklifts - Vimarsana News

How to get your DC ready for driverless forklifts

Planning to introduce automated lift trucks in your DC? Here are some things to consider before you turn the robots loose.

RVL Pharmaceuticals plc Reports Second Quarter 2023 Financial Results; Provides Update on Strategic Business Review - Vimarsana News

RVL Pharmaceuticals plc Reports Second Quarter 2023 Financial Results; Provides Update on Strategic Business Review

2022 includes $15,500 in licensing revenue recognized in connection with an amendment of our License Agreement with Santen, effective March 31, 2022, net of a $500 transaction fee expense classified... -Today at 06:51 am- MarketScreener